4//SEC Filing
Yorke Justin W 4
Accession 0000897069-24-000227
CIK 0001533743other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 4:34 PM ET
Size
5.4 KB
Accession
0000897069-24-000227
Insider Transaction Report
Form 4
Yorke Justin W
Director
Transactions
- Purchase
Common Stock
2024-01-30$2.69/sh+8,000$21,544→ 31,232 total(indirect: By LLC)
Holdings
- 3,737
Common Stock
Footnotes (1)
- [F1]Effective on January 22, 2024, Processa Pharmaceuticals, Inc. effected a 20 to 1 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.
Documents
Issuer
Processa Pharmaceuticals, Inc.
CIK 0001533743
Entity typeother
Related Parties
1- filerCIK 0001361896
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 4:34 PM ET
- Size
- 5.4 KB